Clever Culture Systems Ltd 16 Anster St Adelaide SA 5000 www.cleverculturesystems.com ASX:CC5 PSC BIOTECH PARTNERSHIP EXPANDS US PHARMA SALES REACH Adelaide, Australia, 14 October 2026: Leaders in AI microbiology automation, Clever Culture Systems Ltd (ASX: CC5) (CCS or the Company), is...
PSC Biotech Partnership Expands US Pharma Sales Reach
Filed with ASX · · 3 pages · English
Summary by 6ix AI
Clever Culture Systems Limited has announced a partnership with PSC Biotech to expand its sales reach in the pharmaceutical market across the United States, Canada, and Singapore. The agreement allows PSC Biotech to act as the sole sales agent for the APAS® Independence instrument, targeting regional and medium-sized pharmaceutical manufacturers. As part of the agreement, PSC Biotech will purchase one APAS® Independence instrument and establish a center of excellence at its facility in Pennsylvania. This partnership is expected to create new sales opportunities and enhance the distribution of CCS's innovative technology in the pharmaceutical sector.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Release
Clever Culture Systems Limited on 6ix
Earlier from Clever Culture Systems
- Novo Nordisk Expand Use of APAS Independence
- Half Yearly Report and Accounts
- Quarterly Activities/Appendix 4C Cash Flow Report
- Appendix 4E
- APAS Contact Plate Application Product Launch
Follow Clever Culture Systems into a list and get an email when it puts out news.
Follow Clever Culture Systems